IP25-02: Circulating Tumor DNA (ctDNA) as a Prognostic Biomarker: A Meta-analysis of Androgen Receptor Gene Alterations in Metastatic Castration-Resistant Prostate Cancer.

IP25-02: Circulating Tumor DNA (ctDNA) as a Prognostic Biomarker: A Meta-analysis of Androgen Receptor Gene Alterations in Metastatic Castration-Resistant Prostate Cancer.

Saturday, May 16, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)
145AB
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!